Medpace Holdings Inc (MEDP) Stock Analysis
Verdict: HOLD
Exceptional operational efficiency and backlog growth are priced for perfection, leaving minimal margin of safety against valuation gravity.
Investment score: 64/100
Analysis as of
Is Medpace Holdings Inc stock worth reviewing? The TradeMates thesis
Hold due to superior operational metrics offset by valuation exceeding analyst consensus.
7-factor investment score
- Valuation: 40/100 (weight 20%)
- Financial Health: 95/100 (weight 15%)
- Technical Momentum: 85/100 (weight 15%)
- Earnings Quality: 90/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
Medpace Holdings Inc opportunities and risks
What speaks for MEDP
- Backlog and Guidance Raise
What speaks against MEDP
- Valuation Cap and Analyst Skepticism
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MEDP | 34.8x | 6.2x | 28.1x | 28.8% | 17.7% | 4.4% |
| WAT | 48.5x | 6.6x | 32.5x | 55.0% | 11.9% | 1.1% |
| IQV | 25.5x | 2.1x | 13.8x | 26.1% | 8.3% | 7.4% |
| ILMN | 35.5x | 6.8x | 21.8x | 67.1% | 19.4% | 3.3% |
| MTD | 31.2x | 6.6x | 23.2x | 57.8% | 21.4% | 2.9% |
| WST | 45.2x | 7.5x | 30.3x | 36.8% | 17.0% | 1.7% |
| Peer median | 35.5x | 6.6x | 23.2x | 55.0% | 17.0% | 2.9% |
Frequently asked questions about Medpace Holdings Inc (MEDP)
Is MEDP stock a good investment?
The TradeMates model rates Medpace Holdings Inc as HOLD with an investment score of 64/100. Hold due to superior operational metrics offset by valuation exceeding analyst consensus. This is algorithmic model output, not personal investment advice.
Is MEDP stock a buy?
The TradeMates model verdict for MEDP is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.